Search research articles
Contact Us
Filters
Showing results (1-10 of 116) with videos related to
Page
of 12
Sort By:
Annals of Hematology
|
August 24, 2010
Obituary. In memoriam Stefan Thierfelder
Hans-Jochem Kolb
Blood
|
November 26, 2008
Graft-versus-leukemia effects of transplantation and donor lymphocytes
Hans-Jochem Kolb
Blood
|
November 23, 2013
Mast cells and GVHD: old cells with a new role
Hans-Jochem Kolb
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 3, 2014
As time goes by
Hans-Jochem Kolb
Innere Medizin (Heidelberg, Germany)
|
July 1, 2025
[Donor lymphocyte infusion after allogeneic stem cell transplantation]
Christoph Schmid, Hans-Jochem Kolb
Frontiers in Oncology
|
May 9, 2013
The vigor of defense against non-self: potential superiority of allorestricted T cells in immunotherapy of cancer?
Stefan Burdach, Hans-Jochem Kolb
Medizinische Klinik (Munich, Germany : 1983)
|
April 12, 2007
[Allogeneic stem cell transplantation in the management of acute myeloid leukemia]
Christoph Schmid, Hans-Jochem Kolb
Annals of Hematology
|
June 29, 2020
The FLAMSA concept-past and future
Hans-Jochem Kolb, Christoph Schmid
Annals of Hematology
|
November 10, 2006
Long-term follow-up of allogeneic HSCT for CML reveals significant improvement in the outcome over the last decade
Martin Weisser, Georg Ledderose, Hans Jochem Kolb
European Journal of Cell Biology
|
June 7, 2011
Virus-specific T cells for therapy--approaches, problems, solutions
Andreas Moosmann, Wolfgang Hammerschmidt, Hans-Jochem Kolb
Page
of 12
Search research articles
Search
Showing results (1-10 of 116) with videos related to
Sort By:
Page
of 12
Annals of Hematology
|
August 24, 2010
Obituary. In memoriam Stefan Thierfelder
Hans-Jochem Kolb
Blood
|
November 26, 2008
Graft-versus-leukemia effects of transplantation and donor lymphocytes
Hans-Jochem Kolb
Blood
|
November 23, 2013
Mast cells and GVHD: old cells with a new role
Hans-Jochem Kolb
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 3, 2014
As time goes by
Hans-Jochem Kolb
Innere Medizin (Heidelberg, Germany)
|
July 1, 2025
[Donor lymphocyte infusion after allogeneic stem cell transplantation]
Christoph Schmid, Hans-Jochem Kolb
Frontiers in Oncology
|
May 9, 2013
The vigor of defense against non-self: potential superiority of allorestricted T cells in immunotherapy of cancer?
Stefan Burdach, Hans-Jochem Kolb
Medizinische Klinik (Munich, Germany : 1983)
|
April 12, 2007
[Allogeneic stem cell transplantation in the management of acute myeloid leukemia]
Christoph Schmid, Hans-Jochem Kolb
Annals of Hematology
|
June 29, 2020
The FLAMSA concept-past and future
Hans-Jochem Kolb, Christoph Schmid
Annals of Hematology
|
November 10, 2006
Long-term follow-up of allogeneic HSCT for CML reveals significant improvement in the outcome over the last decade
Martin Weisser, Georg Ledderose, Hans Jochem Kolb
European Journal of Cell Biology
|
June 7, 2011
Virus-specific T cells for therapy--approaches, problems, solutions
Andreas Moosmann, Wolfgang Hammerschmidt, Hans-Jochem Kolb
Page
of 12